Birchview Capital, LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $111 Million distributed in 68 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Bristol Myers Squibb CO with a value of $41.8M, Corcept Therapeutics Inc with a value of $7.54M, Acadia Pharmaceuticals Inc with a value of $4.38M, Prothena Corp Public LTD CO with a value of $4.12M, and Biodesix Inc with a value of $3.61M.
Examining the 13F form we can see an decrease of $6.13M in the current position value, from $117M to 111M.
Birchview Capital, LP is based out at Burlington, VT
Below you can find more details about Birchview Capital, LP portfolio as well as his latest detailed transactions.
Portfolio value
$111 Million
Healthcare: $106 Million
Energy: $4.08 Million
ETFs: $1.17 Million
Stock Holdings Table Market Cap. of $300 Millions to $2 Billions